Back
Cellectar Biosciences Stock Price Chart
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
40
CLRB
Cellectar Biosciences
Last Price:
$0.26
Seasonality Move:
-2.17%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cellectar Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.26 | Buy |
| 20-day SMA: | 0.92 | Sell |
| 50-day SMA: | 1.56 | Sell |
| 200-day SMA: | 2.47 | Sell |
| 8-day EMA: | 0.38 | Sell |
| 20-day EMA: | 0.8 | Sell |
| 50-day EMA: | 1.34 | Sell |
| 200-day EMA: | 2.15 | Sell |
Cellectar Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 10.15 | Sell |
| Chaikin Money Flow: | 3336365 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.45 - 1.67) | Sell |
| Bollinger Bands (100): | (1.28 - 2.36) | Sell |
Cellectar Biosciences Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cellectar Biosciences Stock
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 0.28 while CLRB 8-day simple moving average is 0.26, which is a Buy signal.
-
The stock price of CLRB is 0.28 while Cellectar Biosciences 20-day SMA is 0.92, which makes it a Sell.
-
Cellectar Biosciences 50-day simple moving average is 1.56 while CLRB share price is 0.28, making it a Sell technically.
-
CLRB stock price is 0.28 and Cellectar Biosciences 200-day simple moving average is 2.47, creating a Sell signal.
CLRB Technical Analysis vs Fundamental Analysis
Sell
40
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a SellThe current Cellectar Biosciences [CLRB] share price is $0.28. The Score for CLRB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Cellectar Biosciences Stock Info
Market Cap:
11.4M
Price in USD:
0.28
Share Volume:
4.1M
Cellectar Biosciences 52-Week Range
52-Week High:
4.45
52-Week Low:
0.22
Sell
40
Cellectar Biosciences (CLRB)
is a Sell
Cellectar Biosciences Share Price Forecast
-
What is the Cellectar Biosciences stock price today?The Cellectar Biosciences stock price is 0.28 USD today.
-
Will CLRB stock go up or go down?Cellectar Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Cellectar Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cellectar Biosciences is overvalued.
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 0.28 while CLRB 8-day exponential moving average is 0.38, which is a Sell signal.
-
The stock price of CLRB is 0.28 while Cellectar Biosciences 20-day EMA is 0.80, which makes it a Sell.
-
Cellectar Biosciences 50-day exponential moving average is 1.34 while CLRB share price is 0.28, making it a Sell technically.
-
CLRB stock price is 0.28 and Cellectar Biosciences 200-day simple moving average is 2.15, creating a Sell signal.
Fundamental Analysis of Cellectar Biosciences
Is Cellectar Biosciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.26 per share, and an increase next year of $0.89 per share.
Technical Analysis of Cellectar Biosciences
Should I short Cellectar Biosciences stock?
-
CLRB Moving Average Covergence Divergence (MACD) indicator is -0.42, suggesting Cellectar Biosciences is a Sell
-
Cellectar Biosciences Relative Strength Index (RSI) is 10.15, which suggest Cellectar Biosciences is oversold
-
The Bollinger Bands (25) for Cellectar Biosciences is (0.45 - 1.67), which suggest Cellectar Biosciences is a Sell
-
The Bollinger Bands (100) for Cellectar Biosciences is (1.28 - 2.36), which suggest Cellectar Biosciences is a Sell
* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.